Asymptomatic hepatic portal venous gas with gastric emphysema as a chronic complication of gastrostomy tube placement: a case report
Percutaneous endoscopic gastrostomy feeding is widely used as a route for enteral feeding for patients with impaired swallowing ability, particularly in older patients. Hepatic portal venous gas is a condition that may arise from several causes. Hepatic portal venous gas that develops after an endoscopic procedure is generally reported to be nonfatal, yet there is little information available concerning the characteristics of hepatic portal venous gas as a chronic complication of percutaneous endoscopic gastrostomy feeding.
We experienced a case of hepatic portal venous gas that happened to be detected in an 81-year-old Japanese man with long-term percutaneous endoscopic gastrostomy use who was admitted to our hospital with aspiration pneumonia. While aspiration pneumonia was treated with antibiotics and suspension of tube feedings, he recovered from hepatic portal venous gas without any treatment.
The presence of a percutaneous endoscopic gastrostomy tube may have induced hepatic portal venous gas through a mechanism in which vomiting led to increased abdominal pressure and eventually gastric emphysema. This case suggests that hepatic portal venous gas without any signs of bowel ischemia or emphysematous gastritis can resolve without treatment, which is a finding that could be helpful for clinicians who deal with those supported by percutaneous endoscopic gastrostomy feeding.
KeywordsPercutaneous endoscopic gastrostomy Complication Gastric emphysema Emphysematous gastritis Stroke
Hepatic portal venous gas
Percutaneous endoscopic gastrostomy
Percutaneous endoscopic gastrostomy (PEG) feeding is widely used as a route for enteral feeding, hydration, and medication administration for patients with impaired swallowing ability, particularly in older patients . Although PEG feeding provides the safest and most effective way to maintain a patient’s nutritional state and preserve long-term health , it holds the potential for complications. Two common types of complications are those that occur immediately after the PEG insertion procedure, and those that develop over a longer period. For instance, pneumoperitoneum , ileus , esophageal and gastric perforation , and hepatic portal venous gas (HPVG) [5, 6] are reported as some of the complications that may occur immediately following PEG insertion. On the other hand, deterioration of the gastrostomy site , buried bumper syndrome , colocutaneous fistula , and complications related to tube feeding are classified as chronic complications .
HPVG may arise from several predisposing conditions such as bowel ischemia, elevation of digestive tract pressure, abdominal infection, or endoscopic procedures, among others [10, 11]. The mortality rate for HPVG with necrotizing colitis is approximately 75 % [11, 12], whereas the mortality rate for HPVG without necrotizing colitis is not as high, highlighting the importance of distinguishing whether cases of HPVG may be fatal or nonfatal particularly by ruling out necrotizing colitis . In terms of HPVG as a PEG-related complication, only cases of HPVG occurring immediately following PEG insertion have been reported to date [5, 6]. HPVG after an endoscopic procedure is generally thought of as a benign complication , yet there is little information available concerning the characteristics of HPVG as a chronic complication of PEG feeding.
We present here a case of HPVG that happened to be detected in a patient with a past history of stroke and enteral feeding via PEG; the PEG had been inserted more than 6 months ago. Given the fact that large numbers of older patients are supported by PEG, it is likely that clinicians may experience HPVG in patients with PEG tubes. The present case report highlights that HPVG occurrence may be an important point of consideration for those maintaining the health of patients with chronic PEG feeding.
An 81-year-old Japanese man with a past history of stroke, hypertension, and dyslipidemia presented to our hospital because of respiratory failure. He had presented to the department of neurosurgery in our hospital 9 months earlier with a diagnosis of right cerebral infarction. He then developed left motor hemiparesis, left sensory deficit, and aphasia. He was operated on for PEG tube replacement (Button-type gastrostomy tube; Olympus Medical System Co., Ideal PEG Kit) by a gastroenterologist without complications 6 months before admission. Soon after the procedure he developed recurrent cerebral infarction and it became difficult to communicate with him. He had presented with aspiration pneumonia 3 weeks before the present admission. After being treated with antibiotic therapy for 2 weeks, he was discharged home 3 days prior to the present admission.
In the present case, HPVG arose in a patient supported by a PEG which had been inserted more than 6 months ago; his HPVG resolved without treatment.
The presence of a PEG tube may have induced HPVG through an increase of abdominal pressure due to vomiting. HPVG has several predisposing conditions, which include bowel ischemia, elevation of digestive tract pressure, abdominal infection, endoscopic procedure, gastric emphysema, and emphysematous gastritis [10, 11, 14]. In the present case, accumulations of gas within our patient’s stomach wall were found through a CT scan, leading to a diagnosis of gastric emphysema. Although it is impossible to confirm whether the presence of gastric emphysema in the present case was associated with HPVG, gastric emphysema is generally triggered by secondary mechanical injury of the stomach surface . In addition, increased abdominal pressure due to vomiting before admission in the present case could have led to gastric emphysema via the PEG hole, although possible associations between gastric emphysema and PEG tubes have not yet been explored in the existing literature. While we cannot rule out other potential causes of HPVG, the above hypothesis is consistent with the clinical course of this case, and thus we find a high possibility for HPVG to have been associated with the PEG tube.
It appears that HPVG without any signs of bowel ischemia or emphysematous gastritis can resolve without any treatment in patients who are supported by chronic PEG feeding. HPVG was recognized to be fatal in the 1980s, yet recent increases in cases have demonstrated that non-symptomatic HPVG is not necessarily fatal . In the present case, there were no acute abdominal symptoms on physical examination, and a blood test showed pH 7.445, base excess 1.9 mmol/L, and lactate dehydrogenase 224 IU/l. In addition, CT did not indicate pneumatosis intestinalis or obvious digestive wall thickening. It was therefore judged that there were no signs suggesting bowel ischemia or emphysematous gastritis. While aspiration pneumonia was treated with antibiotics as well as suspension of tube feedings, specific interventions such as gastric decompression or gastrectomy were not carried out. PEG feeding was re-started 7 days after admission, and HPVG was found to be diminishing without sequelae in a CT scan taken 14 days after admission.
In recognition of the growing numbers of older patients supported by PEG, the Japanese government has enforced a new law to reduce the medical fees for PEG placement . There are many patients with long-term PEG use, particularly among older patients, and chronic complications such as HPVG seen in this case may be experienced by clinicians caring for these patients. Excluding patients with a need for acute surgery, it may be possible for non-fatal HPVG to be resolved without aggressive treatment, as seen in the present case.
We experienced a case of HPVG that happened to be detected in a patient with a past history of stroke and enteral feeding by PEG; the PEG had been inserted 6 months earlier. HPVG may be associated with use of PEG tubes, but can be resolved without any treatment in patients without symptoms of bowel ischemia or emphysematous gastritis.
We would like to thank the radiation technologists in Minamisoma Municipal General Hospital for their support in making the figures.
Availability of data and materials
There are no additional data available for this study.
TS, TN, MT, CL, AO, SK, and YK equally contributed to the conception and design of the research; TS, TN, MT, CL, AO, SK, and YK contributed to the design of the research; TS and TN contributed to the acquisition of the data; TS, MT, and CL contributed to the interpretation of the data. All authors drafted the manuscript, critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
The Minamisoma Municipal General Hospital Institutional Ethics Committee waived the necessity for review of case reports.
- 16.Revision of medical fee in 2014. In. Tokyo: Ministry of Health, Labour and Welfare; 2014.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.